Oncobiologics (OTLK)
(Delayed Data from NSDQ)
$6.00 USD
0.00 (0.00%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $5.98 -0.02 (-0.33%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
12/27/2024
Time: -- |
9/2024 | $-0.84 | 0.00% |
Earnings Summary
For their last quarter, Oncobiologics (OTLK) reported earnings of -$0.83 per share, beating the Zacks Consensus Estimate of $-1.06 per share. This reflects a positive earnings surprise of 21.70%. Look out for OTLK's next earnings release expected on December 27, 2024. For the next earning release, we expect the company to report earnings of -$0.84 per share, reflecting a year-over-year increase of 16%.
Earnings History
Price & Consensus
Zacks News for OTLK
Outlook (OTLK) Surges 31% on Regulatory Update for AMD Study
OTLK: What are Zacks experts saying now?
Zacks Private Portfolio Services